Leonurine suppresses prostate cancer growth in vitro and in vivo by regulating miR-18a-5p/SLC40A1 axis

Leonurine suppresses prostate cancer growth in vitro and in vivo by regulating miR-18a-5p/SLC40A1 axis

Prostate cancer is a leading cause of cancer-associated death in males. Leonurine (Leo) is a pleiotropic anti-tumor agent isolated from traditional Chinese herb that was used in gynecologic treatments. However, its pharmacological effect against prostate cancer progression remains unclear. Here, we...

Full description

Bibliographic Details
Main Authors: Bin Liang, Shouxi Cui, Songnian Zou
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Chinese Journal of Physiology
Subjects:
leonurine
mir-18a-5p
prostate cancer
solute carrier family 40 member 1
Online Access:http://www.cjphysiology.org/article.asp?issn=0304-4920;year=2022;volume=65;issue=6;spage=319;epage=327;aulast=Liang

Similar Items

Similar Items